PAVmed Inc. Quarterly Operating Income (Loss) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
PAVmed Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q3 2024.
  • PAVmed Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$11.6M, a 25.4% increase year-over-year.
  • PAVmed Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$55.7M, a 27.7% increase year-over-year.
  • PAVmed Inc. annual Operating Income (Loss) for 2023 was -$68.8M, a 24.5% increase from 2022.
  • PAVmed Inc. annual Operating Income (Loss) for 2022 was -$91.1M, a 67.5% decline from 2021.
  • PAVmed Inc. annual Operating Income (Loss) for 2021 was -$54.4M, a 133% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$55.7M -$11.6M +$3.95M +25.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$59.6M -$13.7M +$2.8M +17% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$62.4M -$14M +$6.37M +31.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$68.8M -$16.4M +$8.22M +33.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$77M -$15.5M +$7.84M +33.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$84.9M -$16.5M +$7M +29.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$91.9M -$20.4M -$766K -3.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$91.1M -$24.6M -$4.92M -25% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$86.2M -$23.4M -$9.7M -71% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$76.5M -$23.5M -$10.5M -81.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$66M -$19.6M -$11.6M -143% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$54.4M -$19.7M -$12.1M -160% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$42.3M -$13.7M -$8.14M -147% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$34.1M -$13M -$7.96M -159% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$26.2M -$8.08M -$2.82M -53.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$23.4M -$7.56M -$2.97M -64.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-06
Q3 2020 -$20.4M -$5.53M -$2.28M -70.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$18.1M -$5.01M -$1.7M -51.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$16.4M -$5.25M -$2.11M -67.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$14.3M -$4.59M -$1.28M -38.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$13M -$3.24M -$675K -26.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$12.3M -$3.32M -$580K -21.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$11.8M -$3.14M -$1.2M -61.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q4 2018 -$10.6M -$3.31M -$1.42M -75.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$9.14M -$2.57M -$601K -30.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$8.54M -$2.74M -$717K -35.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$7.82M -$1.94M +$213K +9.86% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$8.03M -$1.89M -$178K -10.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$7.86M -$1.97M -$39.3K -2.04% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$7.82M -$2.02M -$707K -53.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$7.11M -$2.16M -$1.46M -209% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$5.65M -$1.71M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$1.93M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$1.31M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$697K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.